Navigation Links
Translating the language of capital-raising

Virtually every area of recurring human endeavor has its own lingo. Whether it be at play (like in running, football or racing) or work (think government workers, lawyers, education, military), it seems that when a group of people get together, they develop their own language that few outside of the group can understand. The world of equity capital raising is no exc......

Full article >>> ture financing in which securities are sold at a lower price than originally paid by the holder of the right. Typically, anti-dilution provisions come in two types: full ratchet and weighted average. There are typically exceptions for the adjustment mechanism that carve out situations such as the issuance of certain employee options or existing convertible securities.

Assignment of in......

Full article >>> after a specified date or the occurrence of a certain event.

Capitalization - The combined sources of capital, consisting of debt capital (liabilities) and equity capital (capital stock and retained earnings).

Cap table - Short for capitalization table, it is a summary of a company's issued and outstanding securities.

Convertible notes - Debt instrum......

Full article >>> es are issued at a lower price than the previous round of financing.

Drag-along rights - Rights that enable a shareholder or group of shareholders (usually those who own a controlling interest in the company) to compel other shareholders to sell their stock in the event a purchaser desires to purchase more than what the controlling shareholder(s) own(s).

Exit strategy......

Full article >>> eholder's securities following a public offering.

Mezzanine financing - Typically a hybrid of debt and equity financing that is used to finance the expansion of an existing company. It is generally subordinated to debt provided by senior lenders such as banks.

No-shop requirement - A contractua......

Full article >>> offered to new investors. They are similar to participation rights.

Preferred stock - Stock that gives its holders certain rights, preferences, and privileges over holders of common stock in certain instances.

Put rights - A right that enables the investor to force the company or another investor to buy back the investor's securities, usually for a particular price......

Full article >>> e at which the additional shares were issued. Compare to full-ratchet anti-dilution protection.

Previous articles by Matt Storms

Matt Storms: Securities compliance is part of raising capital

Matt Storms: Raising capital through placement agents
Full article >>>
'"/>


Source:wistechnology.com By Matt Storms 03/25/07


Related biology technology :

1. UW language faculty create multimedia training tool
2. NimbleGen names CFO with capital-raising past
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... Baltimore ... multiple immunoassay-based threat detection technologies by researchers from the Pacific National Northwest ... detection technology was found to have the best level of detection (LOD) ...
(Date:2/23/2017)... 23, 2017 Aviva Systems Biology Corporation ... acquisition of GenWay Biotech Incorporated, a protein solutions ... product offering for both the research and diagnostic ... and enhance capabilities for both entities. GenWay,s 18 years ... will nicely complement ASB,s objective to become a ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Park Systems ... free AFM Luncheon for all SPIE attendees and Park customers on ... one block from the San Jose Convention Center. The luncheon will feature a ...
Breaking Biology Technology:
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
Breaking Biology News(10 mins):